Publication
Charles et al., ELXR engineering (bioRxiv)
DOI 10.64898/2026.01.13.698514v1
Allosteric control improved potency/specificity; in-vivo PCSK9 silencing remains preclinical.
No news refers to this card yet.
Scales
Identifiers
- DOI
- 10.64898/2026.01.13.698514v1
Original sources
Details
- Year
- 2026
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.